Literature DB >> 10219409

Brain involvement in Salla disease.

P Sonninen1, T Autti, T Varho, M Hämäläinen, R Raininko.   

Abstract

BACKGROUND AND
PURPOSE: Our purpose was to document the nature and progression of brain abnormalities in Salla disease, a lysosomal storage disorder, with MR imaging.
METHODS: Fifteen patients aged 1 month to 43 years underwent 26 brain MR examinations. In 10 examinations, signal intensity was measured and compared with that of healthy volunteers of comparable ages.
RESULTS: MR images of a 1-month-old asymptomatic child showed no pathology. In all other patients, abnormal signal intensity was found: on T2-weighted images, the cerebral white matter had a higher signal intensity than the gray matter, except in the internal capsules. In six patients, the white matter was homogeneous on all images. In four patients, the periventricular white matter showed a somewhat lower signal intensity; in five patients, a higher signal intensity. In the peripheral cerebral white matter, the measured signal intensity remained at a high level throughout life. No abnormalities were seen in the cerebellar white matter. Atrophic changes, if present, were relatively mild but were found even in the cerebellum and brain stem. The corpus callosum was always thin.
CONCLUSION: In Salla disease, the cerebral myelination process is defective. In some patients, a centrifugally progressive destructive process is also seen in the cerebral white matter. Better myelination in seen in patients with milder clinical symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10219409

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum.

Authors:  Marjo S van der Knaap; SakkuBai Naidu; Petra J W Pouwels; Simona Bonavita; Rudy van Coster; Lieven Lagae; Jürgen Sperner; Robert Surtees; Raphael Schiffmann; Jakob Valk
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

2.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

Review 3.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

4.  A case of Salla disease with involvement of the cerebellar white matter.

Authors:  T Linnankivi; T Lönnqvist; T Autti
Journal:  Neuroradiology       Date:  2003-01-16       Impact factor: 2.804

5.  Functional characterization of wild-type and mutant human sialin.

Authors:  Pierre Morin; Corinne Sagné; Bruno Gasnier
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

6.  Psychiatric symptoms in Salla disease.

Authors:  Ida Aulanko; Elisa Rahikkala; Jukka Moilanen
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-07       Impact factor: 4.785

Review 7.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

8.  Free sialic acid storage disease without sialuria.

Authors:  Fanny Mochel; Bingzhi Yang; Julie Barritault; Jerry N Thompson; Udo F H Engelke; Nathan H McNeill; William S Benko; Christine R Kaneski; David R Adams; Maria Tsokos; Mones Abu-Asab; Marjan Huizing; Francois Seguin; Ron A Wevers; Jiahuan Ding; Frans W Verheijen; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

9.  Homozygosity for the p.K136E mutation in the SLC17A5 gene as cause of an Italian severe Salla disease.

Authors:  R Biancheri; A Rossi; H A Verbeek; R Schot; F Corsolini; S Assereto; G M S Mancini; F W Verheijen; C Minetti; M Filocamo
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

10.  An Unusual Developmental Profile of Salla Disease in a Patient with the SallaFIN Mutation.

Authors:  Liisa E Paavola; Anne M Remes; Pirkko H Sonninen; Vesa V Kiviniemi; Tapio T Korhonen; Kari Majamaa
Journal:  Case Rep Neurol Med       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.